Background. Despite being a well-known but seldom encountered zoonotic pathogen, diagnosis of Yersinia pseudotuberculosis is not necessarily easy. Infected patients occasionally present with various symptoms resembling Kawasaki disease; thus discriminating the two in the acute phase is challenging. In addition to bacterial culture and serology, novel detection methods based on loop-mediated isothermal amplification (LAMP) are reported in the literature. However, the clinical utility of LAMP-based methods in comparison with the other methods is scarcely documented in the literature.
INTRODUCTION
Yersinia pseudotuberculosis (Y.pstb) is a causative agent of acute enteritis with various complications. Approximately 8 % of Y.pstb cases are known to present with manifestations resembling Kawasaki disease (KD) [1] . The clinical symptoms that Y.pstb infection share with KD are as follows: continuous fever, conjunctivitis, strawberry tongue, cracked lips, cervical lymphadenopathy, rashes. Therefore, early stage discrimination between Y.pstb infection and KD is challenging. Indeed, no diagnostic method to distinguish between the two at the early phase is established to date.
Despite being a well-known zoonotic pathogen, rapid identification of Y.pstb is not easy. Isolation by culture requires several weeks. Furthermore, the detection rate by direct stool culture is reported to be low (approximately one-third of confirmed cases), requiring cold enrichment to increase the chance of detection [2, 3] . Serologic tests are cumbersome, not widely available, and also require several days. Furthermore, serologic tests are not standardized, hindering comparison among studies.
Loop-mediated isothermal amplification (LAMP) is a nucleic acid amplification method, which is widely used for detection of pathogenic micro-organisms, i.e., central nervous system infections, respiratory infections, gastrointestinal tract infections including food poisoning [4] [5] [6] [7] [8] . A LAMP assay to detect Y.pstb DNA with high sensitivity and specificity is also reported [9] .
Although some literature reporting the clinical utility of LAMP assay in diagnosing Y.pstb infection can be found [10] , no direct comparison of the detection rates of Y.pstb among LAMP assay, serological testing, and culture has been reported yet.
The objective of this study is to compare the detection rates of Y.pstb infection among LAMP assay, serological testing and culture test.
METHODS

Study population
All patients suspected of Y.pstb infection, admitted to the Department of Pediatrics, Kawasaki Medical School Hospital during April 2008 through March 2015 were enrolled. Patients presenting with both continuous fever and gastrointestinal symptoms, accompanied by at least one of the following five features -conjunctivitis, changes in the oral cavity and/or lips, cervical lymphadenopathy, rash, changes in the extremities -were suspected of Y.pstb infection. Patients that underwent testing by all three testing methods described hereafter were considered eligible and included in the study. Written informed consent was obtained from the patients' guardian prior to specimen collection.
Specimen collection
Stool specimens were collected from enrolled patients on admission; each specimen was divided into two; one immediately subjected to bacterial culture, the other stored at À80 C until DNA extraction followed by LAMP assay was carried out.
Serum specimens were collected in the acute and convalescent stage and stored at À80 C until serological assay was carried out.
Diagnostic methods
A case was diagnosed as Y.pstb infection when any of the following three methods proved positive; LAMP assay, serological testing or culture.
LAMP assay DNA was extracted from thawed frozen stool using QIAamp DNA Stool Mini kit (QIAGEN GmbH, Hilden Germany) according to the manufacturer supplied instructions; instead of weighing 180-220 mg of stool, the starting material was dispensed using the built-in spoon of 80.734 faeces container (Sarstedt K.K., Tokyo, Japan), a spoonful of which is approximately 200 mg. In brief, a spoonful of stool per specimen was dispensed and subjected to DNA extraction using the kit, finally eluted with 200 µl of Buffer AE [10 mM Tris-HCl, 0.5 mM EDTA (pH 9.0)]. Primer sequences, primer concentrations and reaction conditions were adopted from the literature [9] . Oligonucleotide primers were ordered from Sigma-Aldrich Japan (Tokyo, Japan), used with Loopamp DNA Amplification Kit (Eiken Chemical, Tokyo, Japan). In brief, 5 µl of the DNA eluate was subjected to a 25 µl LAMP reaction. The reaction was carried out at 63 C for 60 min on Loopamp Realtime Turbidimeter LA-500 (Eiken); positive reactions were automatically determined by the build-in feature of the turbidimeter.
Stool culture
Cold enrichment was carried out along with standard bacterial isolation.
For standard bacterial isolation, the stool specimen was plated onto the following five agar plates; MacConkey agar with sorbitol, cefixime and tellurite (CT-SMAC) (Kyokuto Pharmaceutical Industrial, Tokyo, Japan), thiosulfate citrate bile salts sucrose (TCBS) agar (Nissui Pharmaceutical, Tokyo, Japan), Skirrow's Medium (Eiken), bromothymol blue lactose (BTB) agar (Kyokuto) and Salmonella-Shigella (SS) agar (Kyokuto).
For cold enrichment, 0.5 ml of BHI bouillon (Nissui) was added to 9 ml of pre-cooled normal saline, into which an approximately 5 mm sized piece of stool was suspended. The suspension was incubated at 4 C for 3 weeks, during which 10 µl of the suspension was inoculated onto BTB agar and SS agar every 7 days.
Agar plates were incubated under the following conditions: CT-SMAC and TCBS, 37 C for 2 days; Skirrow's medium, 42 C for 2 days; BTB and SS, 25 C for 5 days.
Species identification of grown colonies was carried out using API 20E identification kit (SYSMEX bioM erieux, Tokyo, Japan).
Serological testing
Serological testing was carried out by direct agglutination. Patient serum was diluted 1 : 10 by normal saline following heat inactivation at 56 C for 30 min, from which a twofold serial dilution series of 1 : 10 to 1 : 320 was prepared.
Whole bacterial cells were used as test antigens. Test antigen suspensions were prepared from a panel of Y. pstb strains of the following subserogroups, maintained and stocked at Okayama Prefectural Institute for Environmental Science and Public Health; 1a, 1b, 2a, 2b, 3, 4a, 4b, 5a, 5b and 6. Each strain was plated on BD BBL Trypticase soy agar (Nippon Becton Dickinson Company, Tokyo, Japan), incubated 2 days at 25 C, before working suspensions were prepared. The twonight cultures were washed twice with normal saline, after which a working suspension of each strain, adjusted to a turbidity of McFarland standard No. 0.6, was prepared. 0.2 ml of each suspension was mixed with equal volumes of serial dilution series of patient serum, incubated at 50 C overnight. The titre of a specimen was determined as the maximum dilution in which agglutination was observed.
A case was determined serologically positive if the titre exceeded 1 : 160 in any serum specimen [11] .
Statistical analysis
Fisher's exact test was used to compare the detection rates of the three diagnostic methods. P-values <0.05 were considered statistically significant. Statistical analyses were performed using R software [version 3.2.0; R Core Team (www. R-project.org/)].
RESULTS
During the study period, 32 patients were admitted for Y.pstb infection. Among these patients, 16 underwent all three testing methods and were considered eligible for direct comparison and enrolled in the study. Characteristics of the 16 patients are summarized in Table 1 ; their median age was 64 months (interquartile range, 26.75-106.25), 12 (75 %) were male, eight met the diagnostic criteria of KD among whom six received intravenous immunoglobulin therapy (IVIG) whereas two were spared from IVIG due to defervescence within 5 days, 13 had been administered antibiotics prior to admission.
Results of LAMP assay, serological testing and stool culture are also shown in Table 1 . Among the 16 cases, eight (50 %) by LAMP assay, 13 (81 %) by serological testing and four (25 %) by stool culture proved positive for Y.pstb. All three cases missed by serological testing were successfully detected by LAMP assay. One out of the three cases proved positive by culture as well. LAMP assay detected all four cases detected by faecal culture. All four culture-positive cases proved positive with the aid of cold enrichment; none proved positive for Y.pstb by mere direct plating. LAMP demonstrated 100 % sensitivity and 67 % specificity for culture-positive cases, whereas serology 75 % sensitivity and 17 % specificity (Table 2B , C).
The detection rates tended to be higher in the following order, serological testing, LAMP assay and stool culture. However, no significant difference was noted between any pair among the three methods (serology vs. LAMP, P=0.2; LAMP vs. culture, P=0.077; serology vs. culture, P=1). (Table 2A-C) DISCUSSIONS LAMP assay could detect half of the cases in the early stage of Y.pstb infection. Furthermore, LAMP assay bears the potency of returning results extremely rapidly; typically within a few hours from specimen reception. The detection rate of LAMP assay proved two times higher than stool culture, whereas two times lower than serological testing, though no significant differences between either LAMP assay and serological testing, or LAMP assay and stool culture was found. No cases positive by stool culture was missed by LAMP assay. In this study, LAMP proved 100 % sensitivity and 67 % specificity for culture-positive cases, whereas serology 75 % sensitivity and 17 % specificity; however, due to the small number of cases, interpretation of these results deserve deliberation. Notable is the fact that LAMP assay successfully detected all three cases that were missed by serological analysis. Previous studies point out that serological testing can miss cases, especially young cases [3, 12, 13] ; one of the missed cases in our study is an 18-month-old patient. LAMP assay might serve a complementary role to serological testing in the diagnosis of such patients. There were eight cases of Y.pstb infection that were clinically diagnosed as KD, among which six cases received IVIG therapy. Among the eight cases, four cases proved Y.pstb positive by LAMP assay. Early initiation of IVIG therapy, typically within 5 days of onset, is recommended for KD in order to reduce the risk of developing lifelong coronary sequelae -coronary artery aneurysms. Contrariwise, Y.pstb infections are considered benign and self-limiting, deserving no specific treatments including antibiotics, except for severe cases [1, 14] . Although whether Y.pstb infection fulfilling the diagnosis criteria of KD deserve IVIG therapy or not is yet to be determined [1, 14, 15] , rapid diagnosis by LAMP assay might provide a feasible method for further investigation and/or treatment of such cases.
Furthermore, LAMP assay is advantageous to PCR-based methods in the following aspects. Its utility lies in the feasibility -isothermal amplification that abolishes the use of thermal cyclers, and a far more efficient amplification surpassing that of PCR, resulting in shortened amplification time of typically 15-60 min, whereas typical real-time PCR requires somewhat longer reaction time exceeding 1 h and a costly real-time PCR apparatus [4, [16] [17] [18] . The efficient amplification of LAMP also results in precipitation of magnesium pyrophosphate, which can be observed as turbidity in reaction tubes that can be discriminated by the naked eye [19] ; in contrast, amplification of DNA by conventional PCR by gel electrophoresis requires approximately another hour or more.
The authors are aware of the following limitations. First, no consensus whether stool culture is a suitable surrogate marker for systemic Y.pstb infection is established yet. The fact that serology was superior to stool culture might serve as another proof for this limitation. A case report in the literature [20] describing a case of a Y.pstb infected patient from whom the bacteria was detected only from the biopsied lymph node is also suggestive. Since Y.pstb grows slowly, it is likely to be obscured by outgrowth of other flora in the stool specimen. The optimal phase for stool specimen collection for successful culture of the bacteria is also not clear. Second, serological analyses were performed against 10 subserogroups covering most of the cases in Japan. Since 21 subserogroups, 18 among which with known pathogenicity against humans, are known to date [21] , we might have missed cases caused by the rare untested subserogroups. Furthermore, the prevailing endemic subserogroups of the bacteria differ geographically. Thus, comparison of our results with others would require attention to the test antigens employed, and the region from which the study population were recruited as well.
The authors are also aware of the lack of healthy controls; however due to the following reasons, this is not a critical flaw in design. Healthy individuals are reported to present with antibody titres less than 1 : 160 [22, 23] , and the titres are also known to elevate spontaneously, diminishing within 4 months [24] . Furthermore, only symptomatic subjects are known to yield positive culture [25] .
Currently, Y.pstb infected patients fulfilling the diagnosis criteria of KD are recommended to undergo IVIG treatment. Further studies to investigate whether such cases deserve IVIG administration are warranted. LAMP assay in early stage diagnosis of Y.pstb infection might play an indispensable role in these studies.
In conclusion, our results suggest that LAMP assay bears the potency of rapid diagnosis in the early stage of Y.pstb infection, returning the assay result to the clinical scene within a few hours from stool specimen receipt, which neither serological testing nor bacterial culture can achieve. Its clinical utility as a complementary measure to serological testing was also suggested.
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